Yüklüyor......
Prolonged Use of the Etonogestrel Implant and Levonorgestrel Intrauterine Device - Two Years Beyond FDA-Approved Duration
BACKGROUND: The subdermal contraceptive implant, and the 52mg levonorgestrel intrauterine device (IUD) are currently FDA-approved for three and five years of use respectively. Limited available data has suggested both of these methods are effective beyond that time. Demonstration of prolonged effect...
Kaydedildi:
| Yayımlandı: | Am J Obstet Gynecol |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5449254/ https://ncbi.nlm.nih.gov/pubmed/28147241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2017.01.036 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|